| 英文别名 |
ALMOTRIPTAN;BUTANEDIOIC ACID, HYDROXY-, COMPD WITH 1-[[[3-[2-(DIMETHYLAMINO)ETHYL]-1H-INDOL-5-YL]METHYL]SULFONYL]PYRROLIDINE;ALMOTRIPTAN MALATE;AlmotriptanMaleate;1-[[[2-(Dimethyl-amino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine Malate;1-[[3-(2-dimethylaminoethyl)-5-indolyl]methanesulphonyl]pyrrolidine Malate;LAS-31416 Malate;Lactose Monohydrate;4-Chloro-3-indolyl beta-D-galactopyranoside;ALMOTRIPTAN-D6;N,N-Dimethyl-2-(5-((pyrrolidin-1-ylsulfonyl)-methyl)-1H-indol-3-yl)ethanamine;N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine;N,N-dimethyl-5-[(1-pyrrolidinylsulfonyl)methyl]-1H-Indole-3-ethanamine;Almogran;Axert;UNII-1O4XL5SN61;N,N-Dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]-ethanamine;LAS-31416;LAS-31416-d6;AlMotriptan API;ALMOTRIPTAN(SUBJECTTOPATENETFREE);1-[[3-(2-dimethylaminoethyl)-5-indolyl]methanesulphonyl]pyrrolidine;1-[[3-(2-dimethylaminoethyl)-5-indolyl]methanesulphonyl]pyrrolidine-d6;1-[[[2-(Dimethyl-amino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine;LAS 31416Almotriptan;AB01563047_02;almotriptanum;CS-4530;BSPBio_002731;Q409729;L000846;KBio2_007544;Spectrum5_001554;Almotriptan;SPECTRUM1505204;AB01563047_01;Pyrrolidine, 1-(((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)-;Almotriptan (USAN);WS-02332;BRD-K67601717-001-02-0;KBio3_001951;LAS 31416;NS00014315;D86136;NCGC00095135-04;Tox21_111444_1;CHEMBL1505;NSC 760092;dimethyl(2-{5-[(pyrrolidine-1-sulfonyl)methyl]-1H-indol-3-yl}ethyl)amine;ALMOTRIPTAN [MI];N,N-dimethyl-2-(5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethanamine;BCP06539;1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine;AM84500;CHEBI:520985;SB19515;154323-57-6;SCHEMBL1957;Spectrum2_000498;Spectrum_001884;LAS31416;NCGC00095135-05;EN300-18565831;CCG-39569;D02824;HMS1922L13;ALMOTRIPTAN [VANDF];FT-0651595;N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H- indol-3-yl]-ethanamine;NSC760092;SR-05000001986-1;KBioSS_002414;NCGC00095135-02;AKOS015895080;GTPL7110;AC-8799;Almotriptan-d6;SPBio_000395;A809522;ALMOTRIPTAN [USAN];ALMOTRIPTAN [INN];BIDD:GT0048;DTXSID5044289;Almotriptan [USAN:INN:BAN];CAS-154323-57-6;Almotrintan;PNU-180638;1O4XL5SN61;Tox21 111444;Pyrrolidine, 1-[[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]-;DB00918;NSC-760092;Pharmakon1600-01505204;DTXCID3024289;NCGC00095135-01;KBio2_002408;N,N-dimethyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine;N02CC05;KBio2_004976;Spectrum4_001134;Tox21_111444;KBioGR_001647;1-[[[3-[2-(dimethylamino)ethyl]indol-5-yl]methyl]sulfonyl]pyrrolidine;ALMOTRIPTAN [WHO-DD];SR-05000001986;HY-B0383A;Spectrum3_001006;NCGC00095135-03 |